الفهرس 
cover englshOnly 14 pages are availabe for public view
 |  | from | 186 |  |  |
| | | from | 186 | | |
Abstract
Acute leukemia is most common in children with acute lymphoblastic leukemia ALL the most common subtype. Despite improvements in the treatment of pediatric acute lymphoblastic, approximately one in five patients will develop recurrent disease. The ultimate objective of the study were to reinduce and maintain disease remission for children with relapsed ALL using subjected protocol of salvage therapy and to evaluate its impact on prolonging EFS and RFS.